Adaptive and Individualized AAC Phase II
ConditionCommunication Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorAltec Inc.
About this trial
The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.
Eligibility criteria
Qualifiers
Adults or Children; age greater than or equal to 6 y.o.
Male or female
Able to (a) spell, (b) follow 2-3 step directions, (c) read 40 point text
Have complex communication needs representing a broad spectrum of developmental and acquired severe motor impairments resulting from high spinal cord injury (SCI), chronic Guillain-Barre syndrome, brain stem stroke, cerebral palsy (CP), locked-in syndrome, among others.
Disqualifiers
Non-English speaker.
Inability to follow simple instructions in English.
Medical history of musculoskeletal conditions (arthritis, spondylosis, etc.) that causes pain on head, hand, or foot movement.
Restricted active or passive rotation of head and neck resulting from unstable vertebral, spinal cord, or nerve roots that places the subject at risk for execution of the protocol.
Trial design
Treatments tested in this trial
- Experimental AAC
- Generic AAC
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Altec Inc.
Lead sponsor
University of Nebraska
Collaborator
Source ClinicalTrials.gov